Past studies initially suggested that hepatic Cnr1 deficiency alone prevented the HFD-induced development of hepatic steatosis, insulin resistance, and dyslipidemia, whereas extra-hepatic Cnr1 deficiency was required to prevent HFD-induced obesity (46). The gene discussed is CNR1; the disease is metabolic syndrome.